• Featured Product
  • KD/KO Validated

Cyclin D3 Polyklonaler Antikörper

Cyclin D3 Polyklonal Antikörper für IF, IHC, IP, WB, ELISA

Wirt / Isotyp

Kaninchen / IgG

Getestete Reaktivität

human, Ratte und mehr (1)

Anwendung

WB, IP, IHC, IF, ELISA

Konjugation

Unkonjugiert

Kat-Nr. : 26755-1-AP

Synonyme

CCND3, cyclin D, Cyclin D3, G1/S specific cyclin D3



Geprüfte Anwendungen

Erfolgreiche Detektion in WBC6-Zellen, HeLa-Zellen, Jurkat-Zellen, K-562-Zellen
Erfolgreiche IPK-562-Zellen
Erfolgreiche Detektion in IHChumanes Pankreasgewebe, Rattennierengewebe
Hinweis: Antigendemaskierung mit TE-Puffer pH 9,0 empfohlen. (*) Wahlweise kann die Antigendemaskierung auch mit Citratpuffer pH 6,0 erfolgen.
Erfolgreiche Detektion in IFHeLa-Zellen

Empfohlene Verdünnung

AnwendungVerdünnung
Western Blot (WB)WB : 1:500-1:2000
Immunpräzipitation (IP)IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate
Immunhistochemie (IHC)IHC : 1:50-1:500
Immunfluoreszenz (IF)IF : 1:50-1:500
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, check data in validation data gallery

Produktinformation

26755-1-AP bindet in WB, IP, IHC, IF, ELISA Cyclin D3 und zeigt Reaktivität mit human, Ratten

Getestete Reaktivität human, Ratte
In Publikationen genannte Reaktivitäthuman, Maus, Ratte
Wirt / Isotyp Kaninchen / IgG
Klonalität Polyklonal
Typ Antikörper
Immunogen Cyclin D3 fusion protein Ag25151
Vollständiger Name cyclin D3
Berechnetes Molekulargewicht 33 kDa
Beobachtetes Molekulargewicht 33 kDa
GenBank-ZugangsnummerBC011616
Gene symbol CCND3
Gene ID (NCBI) 896
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Antigen-Affinitätsreinigung
Lagerungspuffer PBS mit 0.02% Natriumazid und 50% Glycerin pH 7.3.
LagerungsbedingungenBei -20°C lagern. Nach dem Versand ein Jahr lang stabil Aliquotieren ist bei -20oC Lagerung nicht notwendig. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

Cyclin D3 belongs to the highly conserved cyclin family, whose members are characterized by a dramatic periodicity in protein abundance through the cell cycle. Cyclins function as regulators of CDK kinases. Different cyclins exhibit distinct expression and degradation patterns which contribute to the temporal coordination of each mitotic event. This cyclin forms a complex with and functions as a regulatory subunit of CDK4 or CDK6, whose activtiy is required for cell cycle G1/S transition. This protein has been shown to interact with and be involved in the phosphorylation of tumor suppressor protein Rb. The CDK4 activity associated with this cyclin was reported to be necessary for cell cycle progression through G2 phase into mitosis after UV radiation.

Protokolle

Produktspezifische Protokolle
WB protocol for Cyclin D3 antibody 26755-1-APProtokoll herunterladen
IHC protocol for Cyclin D3 antibody 26755-1-APProtokoll herunterladen
IF protocol for Cyclin D3 antibody 26755-1-APProtokoll herunterladen
IP protocol for Cyclin D3 antibody 26755-1-APProtokoll herunterladen
Standard-Protokolle
Klicken Sie hier, um unsere Standardprotokolle anzuzeigen

Publikationen

SpeciesApplicationTitle
humanWB,IP

Acta Pharmacol Sin

Inhibition of USP10 induces myeloma cell apoptosis by promoting cyclin D3 degradation

Authors - Yu-Jia Xu
  • KD Validated
humanWB

J Proteome Res

Identification of a Proteomic Signature of Senescence in Primary Human Mammary Epithelial Cells

Authors - Alireza Delfarah
humanWB

Transl Lung Cancer Res

Deubiquitinase USP5 promotes non-small cell lung cancer cell proliferation by stabilizing cyclin D1.

Authors - Zhiwei Zhang
humanIHC

Cancer Gene Ther

Targeting LRIG2 overcomes resistance to EGFR inhibitor in glioblastoma by modulating GAS6/AXL/SRC signaling.

Authors - Minhai Dong
mouseWB

J Cell Mol Med

Cell cycle exit during bortezomib-induced osteogenic differentiation of mesenchymal stem cells was mediated by Xbp1s-upregulated p21Cip1 and p27Kip1.

Authors - Dan Zhang
humanWB

Mol Ther Oncolytics

S119N Mutation of the E3 Ubiquitin Ligase SPOP Suppresses SLC7A1 Degradation to Regulate Hepatoblastoma Progression.

Authors - Weijing He